News
COVID-19 and cancer, still more questions than answers
COVID-19 outbreak poses a severe threat to the health of millions of people worldwide, including cancer patients. What do we know about SARS-CoV-2 infection in this specific population? The analysis of data coming from a prospective cohort established by the…
More evidence-based info on off-patent oncology drugs
The American Association for Cancer Research (AACR) has offered help to the U.S. Food and Drug Administration (FDA) on its ambitious Project Renewal, that aims to evaluate accumulated scientific evidence on safety and efficacy of long-standing off-patent oncology drugs, so…
A step forward in prostate cancer screening optimisation
A single prostate-specific antigen (PSA) measurement in midlife may help to personalise prostate cancer screening, resulting in a reduced risk of overdiagnosis and overtreatment of indolent cancers. The authors of the study just published in JAMA Network Open came to this…
UNESCO pledges to end the gender imbalance in science
[caption id="attachment_9614" align="alignright" width="476"] One of the images with quotes prepared by UNESCO for the International day of Women and Girls in Science 2020[/caption] Science and gender equality are both vital for the achievement of the internationally agreed development goals,…
New evidence shows effectiveness of a single-dose of HPV vaccine
To prevent pre-invasive cervical disease, a single dose of the human papillomavirus (HPV) vaccine could be enough. Investigation of more than 130,000 young women suggests that 1 dose of quadrivalent (4vHPV) vaccine has the same effectiveness of 2 doses, recommended…
Everyone is invited to help with the EU Beat Cancer Plan
Today, on World Cancer Day, the European Commission president Ursula von der Leyen announced the launch of a EU-wide public consultation on the forthcoming “Beating Cancer Plan”, which aims to improve prevention, diagnosis, treatment and care of cancers in the…
Non-cancer drugs repurposing, a new trick to win the onco-challenge?
Originally developed and approved for use in diabetes, inflammation and other non-oncological diseases (even osteoarthritis in dogs), many drugs could have a pivotal role in treating cancer. And they could be more abundant than expected, according to a paper recently…
Genetics of breast cancer: much more than a BRCA story
Over 450 departments and institutions worldwide have contributed to the most comprehensive study conducted so far on breast cancer risk variants whose results have been published in Nature Genetics. The fine mapping of 150 breast cancer risk regions identified nearly…
The European Parliament launches a new committee on cancer
The European Parliament has announced the establishment of a Special Committee on Cancer: "If we combine our research, our resources and our experience, the European Union can beat cancer. Experts are telling us it is possible" said Manfred Weber, Chairman of…
More data on physical activity and reduction of cancer risk
Recommended leisure-time physical activity is associated with a lower risk of 7 types of cancer, according to a new study published on Journal of Clinical Oncology. «In the past decade, our knowledge of the number of cancers linked to physical…